TY - JOUR AU - Hehlmann, R. PY - 2012 DA - 2012// TI - How I, treat CML blast crisis JO - Blood VL - 120 UR - https://doi.org/10.1182/blood-2012-03-380147 DO - 10.1182/blood-2012-03-380147 ID - Hehlmann2012 ER - TY - JOUR AU - Quintas-Cardama, A. AU - Cortes, J. PY - 2009 DA - 2009// TI - Molecular biology of bcr-abl1-positive chronic myeloid leukemia JO - Blood VL - 113 UR - https://doi.org/10.1182/blood-2008-03-144790 DO - 10.1182/blood-2008-03-144790 ID - Quintas-Cardama2009 ER - TY - JOUR AU - Mu, Q. AU - Ma, Q. AU - Wang, Y. AU - Chen, Z. AU - Tong, X. AU - Chen, F. F. PY - 2012 DA - 2012// TI - Cytogenetic profile of 1,863 Ph/BCR-ABL-positive chronic myelogenous leukemia patients from the Chinese population JO - Ann Hematol VL - 91 UR - https://doi.org/10.1007/s00277-012-1421-6 DO - 10.1007/s00277-012-1421-6 ID - Mu2012 ER - TY - JOUR AU - Haferlach, C. AU - Bacher, U. AU - Schnittger, S. AU - Weiss, T. AU - Kern, W. AU - Haferlach, T. PY - 2010 DA - 2010// TI - Similar patterns of chromosome abnormalities in CML occur in addition to the Philadelphia chromosome with or without tyrosine kinase inhibitor treatment JO - Leukemia VL - 24 UR - https://doi.org/10.1038/leu.2009.222 DO - 10.1038/leu.2009.222 ID - Haferlach2010 ER - TY - JOUR AU - Aydin, C. AU - Cetin, Z. AU - Salim, O. AU - Yucel, O. K. AU - Undar, L. AU - Berker, K. S. PY - 2014 DA - 2014// TI - Previously unreported chromosomal aberrations of t(3;3)(q29;q23), t(4;11)(q21;q23), and t(11;18)(q10;q10) in a patient with accelerated phase Ph + CML JO - Case reports in genetics VL - 2014 UR - https://doi.org/10.1155/2014/582016 DO - 10.1155/2014/582016 ID - Aydin2014 ER - TY - JOUR AU - Dastugue, N. AU - Duchayne, E. AU - Huguet, F. AU - Demur, C. AU - Plaisancie, H. AU - Calvas, P. PY - 1992 DA - 1992// TI - t(9;11)(p22;q23) translocation in blastic phase of chronic myeloid leukemia JO - Cancer Genet Cytogenet VL - 63 UR - https://doi.org/10.1016/0165-4608(92)90061-C DO - 10.1016/0165-4608(92)90061-C ID - Dastugue1992 ER - TY - JOUR AU - Haus, O. AU - Noworolska, A. AU - Laskowski, M. AU - Kuliszkiewicz-Janus, M. AU - Kozlowska, J. AU - Harlozinska-Szmyrka, A. PY - 1990 DA - 1990// TI - Prognostic significance of secondary cytogenetic changes and nonspecific cross-reacting antigen (NCA) in patients with Ph-positive chronic myeloid leukemia JO - Exp Mol Pathol VL - 52 UR - https://doi.org/10.1016/0014-4800(90)90008-2 DO - 10.1016/0014-4800(90)90008-2 ID - Haus1990 ER - TY - JOUR AU - Li, L. AU - Ritterbach, J. AU - Harbott, J. AU - Schroyens, W. AU - Lohmeyer, J. AU - Pralle, H. PY - 1993 DA - 1993// TI - Blastic phase chronic myeloid leukemia with a four-break rearrangement: t(11;9)(9;22)(q23;p22q34;q11) JO - Cancer Genet Cytogenet VL - 68 UR - https://doi.org/10.1016/0165-4608(93)90009-B DO - 10.1016/0165-4608(93)90009-B ID - Li1993 ER - TY - JOUR AU - Nishii, K. AU - Usui, E. AU - Sakakura, M. AU - Miyata, E. AU - Ridge, S. A. AU - Ford, A. M. PY - 2001 DA - 2001// TI - Additional t(11;17)(q23;q21) in a patient with Philadelphia-positive mixed lineage antigen-expressing leukemia JO - Cancer Genet Cytogenet VL - 126 UR - https://doi.org/10.1016/S0165-4608(00)00382-4 DO - 10.1016/S0165-4608(00)00382-4 ID - Nishii2001 ER - TY - JOUR AU - Otero, L. AU - Moellmann, A. C. AU - Pombo-de-Oliveira, M. S. AU - Ornellas, M. H. AU - Pires, V. AU - Bouzas, L. F. PY - 2007 DA - 2007// TI - Additional t(1;11)(q21;q23) with mixed lineage leukemia rearrangement in T-blastic crisis of a Ph-positive chronic myeloid leukemia JO - Eur J Haematol VL - 79 UR - https://doi.org/10.1111/j.1600-0609.2007.00884.x DO - 10.1111/j.1600-0609.2007.00884.x ID - Otero2007 ER - TY - JOUR AU - Rajcan-Separovic, E. AU - Bence-Bruckler, I. AU - Wells, P. AU - Wang, H. PY - 1999 DA - 1999// TI - Fluorescence in situ hybridization analysis of complex translocations in two newly diagnosed Philadelphia chromosome-positive chronic myelogenous leukemia patients JO - Cancer Genet Cytogenet VL - 114 UR - https://doi.org/10.1016/S0165-4608(99)00047-3 DO - 10.1016/S0165-4608(99)00047-3 ID - Rajcan-Separovic1999 ER - TY - JOUR AU - Royer-Pokora, B. AU - Hildebrandt, B. AU - Redmann, A. AU - Herold, C. AU - Kronenwett, R. AU - Haas, R. PY - 2003 DA - 2003// TI - Simultaneous occurrence of a t(9;22) (Ph) with a t(2;11) in a patient with CML and emergence of a new clone with the t(2;11) alone after imatinib mesylate treatment JO - Leukemia VL - 17 UR - https://doi.org/10.1038/sj.leu.2402877 DO - 10.1038/sj.leu.2402877 ID - Royer-Pokora2003 ER - TY - JOUR AU - Suzuki, K. AU - Sugawara, T. AU - Kowata, S. AU - Utsugizawa, T. AU - Ito, S. AU - Murai, K. PY - 2004 DA - 2004// TI - Uncommon karyotypic abnormality, t(11;19)(q23;p13.3), in a patient with blastic phase of chronic myeloid leukemia JO - Cancer Genet Cytogenet VL - 150 UR - https://doi.org/10.1016/j.cancergencyto.2003.09.005 DO - 10.1016/j.cancergencyto.2003.09.005 ID - Suzuki2004 ER - TY - JOUR AU - Zamecnikova, A. PY - 2011 DA - 2011// TI - Acquisition of mixed lineage leukemia rearrangement in a chronic myeloid leukemia patient while on imatinib JO - Hematology reports VL - 3 UR - https://doi.org/10.4081/hr.2011.e13 DO - 10.4081/hr.2011.e13 ID - Zamecnikova2011 ER - TY - JOUR AU - Armstrong, S. A. AU - Look, A. T. PY - 2005 DA - 2005// TI - Molecular genetics of acute lymphoblastic leukemia JO - J Clin Oncol VL - 23 UR - https://doi.org/10.1200/JCO.2005.05.047 DO - 10.1200/JCO.2005.05.047 ID - Armstrong2005 ER - TY - JOUR AU - Tomizawa, D. AU - Koh, K. AU - Sato, T. AU - Kinukawa, N. AU - Morimoto, A. AU - Isoyama, K. PY - 2007 DA - 2007// TI - Outcome of risk-based therapy for infant acute lymphoblastic leukemia with or without an MLL gene rearrangement, with emphasis on late effects: a final report of two consecutive studies, MLL96 and MLL98, of the Japan Infant Leukemia Study Group JO - Leukemia VL - 21 UR - https://doi.org/10.1038/sj.leu.2404903 DO - 10.1038/sj.leu.2404903 ID - Tomizawa2007 ER - TY - JOUR AU - Schoch, C. AU - Schnittger, S. AU - Klaus, M. AU - Kern, W. AU - Hiddemann, W. AU - Haferlach, T. PY - 2003 DA - 2003// TI - AML with 11q23/MLL abnormalities as defined by the WHO classification: incidence, partner chromosomes, FAB subtype, age distribution, and prognostic impact in an unselected series of 1897 cytogenetically analyzed AML cases JO - Blood VL - 102 UR - https://doi.org/10.1182/blood-2003-02-0434 DO - 10.1182/blood-2003-02-0434 ID - Schoch2003 ER - TY - JOUR AU - Meyer, C. AU - Hofmann, J. AU - Burmeister, T. AU - Groger, D. AU - Park, T. S. AU - Emerenciano, M. PY - 2013 DA - 2013// TI - The MLL recombinome of acute leukemias in 2013 JO - Leukemia VL - 27 UR - https://doi.org/10.1038/leu.2013.135 DO - 10.1038/leu.2013.135 ID - Meyer2013 ER - TY - JOUR AU - Zeisig, B. B. AU - Schreiner, S. AU - Garcia-Cuellar, M. P. AU - Slany, R. K. PY - 2003 DA - 2003// TI - Transcriptional activation is a key function encoded by MLL fusion partners JO - Leukemia VL - 17 UR - https://doi.org/10.1038/sj.leu.2402804 DO - 10.1038/sj.leu.2402804 ID - Zeisig2003 ER - TY - JOUR AU - Slany, R. K. PY - 2009 DA - 2009// TI - The molecular biology of mixed lineage leukemia JO - Haematologica VL - 94 UR - https://doi.org/10.3324/haematol.2008.002436 DO - 10.3324/haematol.2008.002436 ID - Slany2009 ER - TY - JOUR AU - Harper, D. P. AU - Aplan, P. D. PY - 2008 DA - 2008// TI - Chromosomal rearrangements leading to MLL gene fusions: clinical and biological aspects JO - Cancer Res VL - 68 UR - https://doi.org/10.1158/0008-5472.CAN-08-2208 DO - 10.1158/0008-5472.CAN-08-2208 ID - Harper2008 ER - TY - JOUR AU - Manara, E. AU - Baron, E. AU - Tregnago, C. AU - Aveic, S. AU - Bisio, V. AU - Bresolin, S. PY - 2014 DA - 2014// TI - MLL-AF6 fusion oncogene sequesters AF6 into the nucleus to trigger RAS activation in myeloid leukemia JO - Blood VL - 124 UR - https://doi.org/10.1182/blood-2013-09-525741 DO - 10.1182/blood-2013-09-525741 ID - Manara2014 ER - TY - JOUR AU - Cortes, J. AU - Talpaz, M. AU - O’Brien, S. AU - Rios, M. B. AU - Majlis, A. AU - Keating, M. PY - 1998 DA - 1998// TI - Suppression of cytogenetic clonal evolution with interferon alfa therapy in patients with Philadelphia chromosome-positive chronic myelogenous leukemia JO - J Clin Oncol VL - 16 ID - Cortes1998 ER - TY - JOUR AU - Cortes, J. E. AU - Talpaz, M. AU - Giles, F. AU - O’Brien, S. AU - Rios, M. B. AU - Shan, J. PY - 2003 DA - 2003// TI - Prognostic significance of cytogenetic clonal evolution in patients with chronic myelogenous leukemia on imatinib mesylate therapy JO - Blood VL - 101 UR - https://doi.org/10.1182/blood-2002-09-2790 DO - 10.1182/blood-2002-09-2790 ID - Cortes2003 ER - TY - JOUR AU - O’Dwyer, M. E. AU - Mauro, M. J. AU - Kurilik, G. AU - Mori, M. AU - Balleisen, S. AU - Olson, S. PY - 2002 DA - 2002// TI - The impact of clonal evolution on response to imatinib mesylate (STI571) in accelerated phase CML JO - Blood VL - 100 UR - https://doi.org/10.1182/blood-2002-03-0777 DO - 10.1182/blood-2002-03-0777 ID - O’Dwyer2002 ER - TY - JOUR AU - Verma, D. AU - Kantarjian, H. AU - Shan, J. AU - O’Brien, S. AU - Estrov, Z. AU - Garcia-Manero, G. PY - 2010 DA - 2010// TI - Survival outcomes for clonal evolution in chronic myeloid leukemia patients on second generation tyrosine kinase inhibitor therapy JO - Cancer VL - 116 ID - Verma2010 ER - TY - JOUR AU - Fabarius, A. AU - Leitner, A. AU - Hochhaus, A. AU - Muller, M. C. AU - Hanfstein, B. AU - Haferlach, C. PY - 2011 DA - 2011// TI - Impact of additional cytogenetic aberrations at diagnosis on prognosis of CML: long-term observation of 1151 patients from the randomized CML Study IV JO - Blood VL - 118 UR - https://doi.org/10.1182/blood-2011-08-373902 DO - 10.1182/blood-2011-08-373902 ID - Fabarius2011 ER - TY - JOUR AU - Baccarani, M. AU - Deininger, M. W. AU - Rosti, G. AU - Hochhaus, A. AU - Soverini, S. AU - Apperley, J. F. PY - 2013 DA - 2013// TI - European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013 JO - Blood VL - 122 UR - https://doi.org/10.1182/blood-2013-05-501569 DO - 10.1182/blood-2013-05-501569 ID - Baccarani2013 ER - TY - JOUR AU - Giugliano, E. AU - Rege-Cambrin, G. AU - Scaravaglio, P. AU - Wlodarska, I. AU - Emanuel, B. AU - Stul, M. PY - 2002 DA - 2002// TI - Two new translocations involving the 11q23 region map outside the MLL locus in myeloid leukemias JO - Haematologica VL - 87 ID - Giugliano2002 ER - TY - JOUR AU - Cox, M. C. AU - Panetta, P. AU - Lo-Coco, F. AU - Poeta, G. AU - Venditti, A. AU - Maurillo, L. PY - 2004 DA - 2004// TI - Chromosomal aberration of the 11q23 locus in acute leukemia and frequency of MLL gene translocation: results in 378 adult patients JO - Am J Clin Pathol VL - 122 UR - https://doi.org/10.1309/RX27R8GJQM330C22 DO - 10.1309/RX27R8GJQM330C22 ID - Cox2004 ER - TY - JOUR AU - Kornblau, S. M. AU - Qiu, Y. H. AU - Zhang, N. AU - Singh, N. AU - Faderl, S. AU - Ferrajoli, A. PY - 2011 DA - 2011// TI - Abnormal expression of FLI1 protein is an adverse prognostic factor in acute myeloid leukemia JO - Blood VL - 118 UR - https://doi.org/10.1182/blood-2011-04-348052 DO - 10.1182/blood-2011-04-348052 ID - Kornblau2011 ER - TY - JOUR AU - Baud, V. AU - Lipinski, M. AU - Rassart, E. AU - Poliquin, L. AU - Bergeron, D. PY - 1991 DA - 1991// TI - The human homolog of the mouse common viral integration region, FLI1, maps to 11q23-q24 JO - Genomics VL - 11 UR - https://doi.org/10.1016/0888-7543(91)90124-W DO - 10.1016/0888-7543(91)90124-W ID - Baud1991 ER - TY - JOUR AU - Loriaux, M. AU - Deininger, M. PY - 2004 DA - 2004// TI - Clonal cytogenetic abnormalities in Philadelphia chromosome negative cells in chronic myeloid leukemia patients treated with imatinib JO - Leuk Lymphoma VL - 45 UR - https://doi.org/10.1080/10428190410001723278 DO - 10.1080/10428190410001723278 ID - Loriaux2004 ER - TY - JOUR AU - Jabbour, E. AU - Kantarjian, H. M. AU - Abruzzo, L. V. AU - O’Brien, S. AU - Garcia-Manero, G. AU - Verstovsek, S. PY - 2007 DA - 2007// TI - Chromosomal abnormalities in Philadelphia chromosome negative metaphases appearing during imatinib mesylate therapy in patients with newly diagnosed chronic myeloid leukemia in chronic phase JO - Blood VL - 110 UR - https://doi.org/10.1182/blood-2007-01-070045 DO - 10.1182/blood-2007-01-070045 ID - Jabbour2007 ER - TY - JOUR AU - Kovitz, C. AU - Kantarjian, H. AU - Garcia-Manero, G. AU - Abruzzo, L. V. AU - Cortes, J. PY - 2006 DA - 2006// TI - Myelodysplastic syndromes and acute leukemia developing after imatinib mesylate therapy for chronic myeloid leukemia JO - Blood VL - 108 UR - https://doi.org/10.1182/blood-2006-04-017400 DO - 10.1182/blood-2006-04-017400 ID - Kovitz2006 ER - TY - STD TI - Perel JM, McCarthy C, Walker O, Irving I, Williams B, Kennedy GA. Clinical significance of development of Philadelphia-chromosome negative clones in patients with chronic myeloid leukemia treated with imatinib mesylate. Haematologica. 2005;90 Suppl:ECR25. ID - ref36 ER - TY - JOUR AU - Bacher, U. AU - Hochhaus, A. AU - Berger, U. AU - Hiddemann, W. AU - Hehlmann, R. AU - Haferlach, T. PY - 2005 DA - 2005// TI - Clonal aberrations in Philadelphia chromosome negative hematopoiesis in patients with chronic myeloid leukemia treated with imatinib or interferon alpha JO - Leukemia VL - 19 UR - https://doi.org/10.1038/sj.leu.2403607 DO - 10.1038/sj.leu.2403607 ID - Bacher2005 ER - TY - JOUR AU - Andersen, M. K. AU - Pedersen-Bjergaard, J. AU - Kjeldsen, L. AU - Dufva, I. H. AU - Brondum-Nielsen, K. PY - 2002 DA - 2002// TI - Clonal Ph-negative hematopoiesis in CML after therapy with imatinib mesylate is frequently characterized by trisomy 8 JO - Leukemia VL - 16 UR - https://doi.org/10.1038/sj.leu.2402634 DO - 10.1038/sj.leu.2402634 ID - Andersen2002 ER - TY - JOUR AU - Chee, Y. L. AU - Vickers, M. A. AU - Stevenson, D. AU - Holyoake, T. L. AU - Culligan, D. J. PY - 2003 DA - 2003// TI - Fatal myelodysplastic syndrome developing during therapy with imatinib mesylate and characterised by the emergence of complex Philadelphia negative clones JO - Leukemia VL - 17 UR - https://doi.org/10.1038/sj.leu.2402842 DO - 10.1038/sj.leu.2402842 ID - Chee2003 ER - TY - JOUR AU - Quintas-Cardama, A. AU - Kantarjian, H. AU - Abruzzo, L. V. AU - Cortes, J. PY - 2007 DA - 2007// TI - Extramedullary BCR-ABL1-negative myeloid leukemia in a patient with chronic myeloid leukemia and synchronous cytogenetic abnormalities in Philadelphia-positive and -negative clones during imatinib therapy JO - Leukemia VL - 21 UR - https://doi.org/10.1038/sj.leu.2404865 DO - 10.1038/sj.leu.2404865 ID - Quintas-Cardama2007 ER - TY - JOUR AU - Perrotti, D. AU - Jamieson, C. AU - Goldman, J. AU - Skorski, T. PY - 2010 DA - 2010// TI - Chronic myeloid leukemia: mechanisms of blastic transformation JO - J Clin Invest VL - 120 UR - https://doi.org/10.1172/JCI41246 DO - 10.1172/JCI41246 ID - Perrotti2010 ER - TY - JOUR AU - Lee, S. G. AU - Park, T. S. AU - Oh, S. H. AU - Park, J. C. AU - Yang, Y. J. AU - Marschalek, R. PY - 2011 DA - 2011// TI - De novo acute myeloid leukemia associated with t(11;17)(q23;q25) and MLL-SEPT9 rearrangement in an elderly patient: a case study and review of the literature JO - Acta Haematol VL - 126 UR - https://doi.org/10.1159/000329389 DO - 10.1159/000329389 ID - Lee2011 ER -